Thiazide Discontinuation in Chronic Kidney Disease Hypertension Management: A Retrospective Chart Review
The Permanente Journal · 2024
DOI: 10.7812/tpp/23.143 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Permanente Journal, 2024. Verfasst von Kirsten Dalangin Vea und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Administration, Kaiser Permanente West Los Angeles Medical Center, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Hypertension, Glomerular Filtration Rate, Thiazides. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacy Administration, Kaiser Permanente West Los Angeles Medical Center, Los Angeles, CA, USA.
- Department of Nephrology, Kaiser Permanente West Los Angeles Medical Center, Los Angeles, CA, USA.
- Renal Business Group, Southern California Permanente Medical Group, Pasadena, CA, USA.
ORCID-Profile: Kirsten Dalangin Vea
Zitieren
APA
Vea, K. D., Nguyen, L. A., McGill, K., Park, J. C., & Selevan, D. (2024). Thiazide Discontinuation in Chronic Kidney Disease Hypertension Management: A Retrospective Chart Review. The Permanente Journal. https://doi.org/10.7812/tpp/23.143
Vancouver
Vea KD, Nguyen LA, McGill K, Park JC, Selevan D. Thiazide Discontinuation in Chronic Kidney Disease Hypertension Management: A Retrospective Chart Review. The Permanente Journal. 2024. doi:10.7812/tpp/23.143
BibTeX
@article{Vea2024,
author = {Vea, Kirsten Dalangin and Nguyen, Leigh Anh and McGill, Kristine and Park, Jong C and Selevan, David},
title = {Thiazide Discontinuation in Chronic Kidney Disease Hypertension Management: A Retrospective Chart Review},
journal = {The Permanente Journal},
year = {2024},
doi = {10.7812/tpp/23.143}
}
EUVIMED